These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 28068330

  • 1. Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Tsuruta-Kishino T, Koya J, Kataoka K, Narukawa K, Sumitomo Y, Kobayashi H, Sato T, Kurokawa M.
    Oncogene; 2017 Jun 08; 36(23):3300-3311. PubMed ID: 28068330
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.
    Zaleskas VM, Krause DS, Lazarides K, Patel N, Hu Y, Li S, Van Etten RA.
    PLoS One; 2006 Dec 20; 1(1):e18. PubMed ID: 17183644
    [Abstract] [Full Text] [Related]

  • 6. Characterization of murine JAK2V617F-positive myeloproliferative disease.
    Bumm TG, Elsea C, Corbin AS, Loriaux M, Sherbenou D, Wood L, Deininger J, Silver RT, Druker BJ, Deininger MW.
    Cancer Res; 2006 Dec 01; 66(23):11156-65. PubMed ID: 17145859
    [Abstract] [Full Text] [Related]

  • 7. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S, Michiels JJ.
    Semin Thromb Hemost; 2006 Jun 01; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [Abstract] [Full Text] [Related]

  • 8. The polycythemia vera-associated Jak2 V617F mutant induces tumorigenesis in nude mice.
    Abe M, Funakoshi-Tago M, Tago K, Kamishimoto J, Aizu-Yokota E, Sonoda Y, Kasahara T.
    Int Immunopharmacol; 2009 Jul 01; 9(7-8):870-7. PubMed ID: 19327411
    [Abstract] [Full Text] [Related]

  • 9. JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.
    Patel AB, Franzini A, Leroy E, Kim SJ, Pomicter AD, Genet L, Xiao M, Yan D, Ahmann JM, Agarwal AM, Clair P, Addada J, Lambert J, Salmon M, Gleich GJ, Cross NCP, Constantinescu SN, O'Hare T, Prchal JT, Deininger MW.
    Blood; 2019 Dec 26; 134(26):2388-2398. PubMed ID: 31697804
    [Abstract] [Full Text] [Related]

  • 10. Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
    Hoermann G, Cerny-Reiterer S, Herrmann H, Blatt K, Bilban M, Gisslinger H, Gisslinger B, Müllauer L, Kralovics R, Mannhalter C, Valent P, Mayerhofer M.
    FASEB J; 2012 Feb 26; 26(2):894-906. PubMed ID: 22051730
    [Abstract] [Full Text] [Related]

  • 11. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
    Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR.
    N Engl J Med; 2007 Feb 01; 356(5):459-68. PubMed ID: 17267906
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
    Lakey MA, Pardanani A, Hoyer JD, Nguyen PL, Lasho TL, Tefferi A, Hanson CA.
    Am J Clin Pathol; 2010 Jun 01; 133(6):942-8. PubMed ID: 20472853
    [Abstract] [Full Text] [Related]

  • 13. Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs.
    Duek A, Lundberg P, Shimizu T, Grisouard J, Karow A, Kubovcakova L, Hao-Shen H, Dirnhofer S, Skoda RC.
    Blood; 2014 Jun 19; 123(25):3943-50. PubMed ID: 24820309
    [Abstract] [Full Text] [Related]

  • 14. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.
    Arch Pathol Lab Med; 2014 Sep 19; 138(9):1203-9. PubMed ID: 25171702
    [Abstract] [Full Text] [Related]

  • 15. Polycythemia vera: scientific advances and current practice.
    Tefferi A, Spivak JL.
    Semin Hematol; 2005 Oct 19; 42(4):206-20. PubMed ID: 16210034
    [Abstract] [Full Text] [Related]

  • 16. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
    Passamonti F, Rumi E, Pietra D, Elena C, Boveri E, Arcaini L, Roncoroni E, Astori C, Merli M, Boggi S, Pascutto C, Lazzarino M, Cazzola M.
    Leukemia; 2010 Sep 19; 24(9):1574-9. PubMed ID: 20631743
    [Abstract] [Full Text] [Related]

  • 17. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ, Berneman Z, Schroyens W, De Raeve H.
    Acta Haematol; 2015 Sep 19; 133(1):36-51. PubMed ID: 25116092
    [Abstract] [Full Text] [Related]

  • 18. Imatinib effect on growth and signal transduction in polycythemia vera.
    Gaikwad A, Verstovsek S, Yoon D, Chang KT, Manshouri T, Nussenzveig R, Cortes J, Vainchenker W, Prchal JT.
    Exp Hematol; 2007 Jun 19; 35(6):931-8. PubMed ID: 17533047
    [Abstract] [Full Text] [Related]

  • 19. Transformation of polycythemia vera to chronic myelogenous leukemia.
    Mirza I, Frantz C, Clarke G, Voth AJ, Turner R.
    Arch Pathol Lab Med; 2007 Nov 19; 131(11):1719-24. PubMed ID: 17979493
    [Abstract] [Full Text] [Related]

  • 20. Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F.
    Shide K, Shimoda HK, Kumano T, Karube K, Kameda T, Takenaka K, Oku S, Abe H, Katayose KS, Kubuki Y, Kusumoto K, Hasuike S, Tahara Y, Nagata K, Matsuda T, Ohshima K, Harada M, Shimoda K.
    Leukemia; 2008 Jan 19; 22(1):87-95. PubMed ID: 18033315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.